✨ Health Notices




NEW ZEALAND GAZETTE, No. 35

22 MARCH 2012


Health

Intellectual Disability (Compulsory Care and Rehabilitation) Act 2003

Appointment of Compulsory Care Co-ordinator

Under section 140 of the Intellectual Disability (Compulsory Care and Rehabilitation) Act 2003, I appoint the following person as a compulsory care co-ordinator for the named geographical and operational areas listed below.

Midland region being the geographical area including Waikato, Bay of Plenty, Taranaki and Tairawhiti:

Michelle Cameron

The appointment of the above-named person takes effect on the date this notice is published in the New Zealand Gazette and ends on 24 March 2017.

Dated at Wellington this 2nd day of March 2012.

KEVIN WOODS, Director-General of Health.

go1788


Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Ephedrine Hydrochloride Injection
Active Ingredient: Ephedrine hydrochloride 30mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Max Health Limited
Manufacturer: Martindale Pharmaceuticals, Romford, United Kingdom

Product: Rapamune
Active Ingredient: Sirolimus 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Wyeth Pharmaceuticals Inc, New York, United States of America
Patheon Inc, Ontario, Canada

Product: Rapamune
Active Ingredient: Sirolimus 1mg
Dosage Form: Coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Wyeth Pharmaceutical Company, Guayama, Puerto Rico
Wyeth Pharmaceuticals Inc, New York, United States of America

Product: Rapamune
Active Ingredient: Sirolimus 2mg
Dosage Form: Coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Wyeth Pharmaceutical Company, Guayama, Puerto Rico
Wyeth Pharmaceuticals Inc, New York, United States of America

Product: Rapamune
Active Ingredient: Sirolimus 0.5mg
Dosage Form: Tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Wyeth Pharmaceutical Company, Guayama, Puerto Rico

Product: Winglore
Active Ingredient: Ipilimumab 53.5mg
Dosage Form: Concentrate for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Baxter Pharmaceutical Solutions LLC, Indiana, United States of America

Product: Winglore
Active Ingredient: Ipilimumab 213mg
Dosage Form: Concentrate for injection
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Baxter Pharmaceutical Solutions LLC, Indiana, United States of America



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2012, No 35





✨ LLM interpretation of page content

πŸ₯ Appointment of Compulsory Care Co-ordinator

πŸ₯ Health & Social Welfare
2 March 2012
Appointment, Compulsory care co-ordinator, Intellectual disability, Midland region
  • Michelle Cameron, Appointed compulsory care co-ordinator

  • KEVIN WOODS, Director-General of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Ephedrine Hydrochloride, Rapamune, Winglore